Up a level |
Elliot, Emilie R ORCID: 0000-0001-7736-9883, Wang, Xinzhu, Singh, Suveer, Simmons, Bryony ORCID: 0000-0002-3207-9935, Vera, Jaime H ORCID: 0000-0002-1165-0573, Miller, Robert F ORCID: 0000-0003-2067-4291, Fitzpatrick, Colin ORCID: 0000-0001-5764-5860, Moyle, Graeme, McClure, Myra and Boffito, Marta ORCID: 0000-0002-2213-1103
(2019)
Increased Dolutegravir Peak Concentrations in People Living With Human Immunodeficiency Virus Aged 60 and Over, and Analysis of Sleep Quality and Cognition.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68 (1).
pp. 87-95.
Sokhela, Simiso, Bosch, Bronwyn, Hill, Andrew, Simmons, Bryony, Woods, Joana, Johnstone, Hilary, Akpomiemie, Godspower, Ellis, Leah, Owen, Andrew ORCID: 0000-0002-9819-7651, Casas, Carmen Perez et al (show 1 more authors)
(2022)
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (10).
pp. 2706-2712.
Waitt, Catriona ORCID: 0000-0003-0134-5855, Orrell, Catherine, Walimbwa, Stephen, Singh, Yashna, Kintu, Kenneth, Simmons, Bryony, Kaboggoza, Julian ORCID: 0000-0001-9510-0474, Sihlangu, Mary, Coombs, Julie-Anne, Malaba, Thoko et al (show 13 more authors)
(2019)
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
PLOS MEDICINE, 16 (9).
e1002895-.